Table 5. NF-κB Enriched Targets.
| Regulation | Pattern | Time (Hr) | Transcripts |
NF-κB Sites |
||
|---|---|---|---|---|---|---|
| ALL NF-κB | Prom | Total | Unique | |||
| Down | 18/1 | 2 | 18.7 | 31.3 | 3.3 | 1.7 |
| 5 | 17.2 | 27.2 | 2.1 | 1.5 | ||
| Up | 2 | 12.6 | 23.3 | 2.4 | 1.3 | |
| 5 | 18.3 | 30.3 | 2.5 | 1.3 | ||
| Down | 90/5 | 2 | 13.5 | 23.5 | 1.0 | 0.8 |
| 5 | 10.7 | 18.5 | 0.7 | 0.6 | ||
| Up | 2 | 19.6 | 30.6 | 3.0 | 1.4 | |
| 5 | 25.1 | 36.5 | 4.5 | 2.5 | ||
NF-κB sites are enriched in transcripts following 5 hr stimulation by the 90/5 pattern. Transcripts up- and down-regulated by patterned stimulation for 2 hr and 5 hr by 18/1 or 90/5 stimulation patterns ( >1.4-fold and p < 0.05) were analyzed by DIRE. Transcripts containing NF-κB sites (NF-κB, NF-κB p50, and NF-κB p65) were filtered and summarized by transcript and TFBS. For NFK analysis by transcripts, the % of NFK-containing transcripts to total transcripts (Transcripts within proximal promoter or across intergenic, upstream, and ECRs) is given. For NF-κB TFBS analysis by site, unique sites or total # of observations were considered. In all 4 types of analysis, there was significant enrichment in NFK sites for 5 hr at 90/5 [Mean and 95% confidence interval for transcripts: 17.0 ± 3.2% (All NF-κB), 27.6 ± 3.9% (Promoter only); for NF-κB sites: 2.4 ± 0.8% (Total) and 1.4 ± 0.4% (Unique)].